• DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results

    10 days ago - By San Diego Biotechnology

    Call will feature data from DURECT's late-breaking oral presentation at the 2019 Liver Meeting®
    CUPERTINO, Calif., Nov. 6, 2019 /PRNewswire/ - DURECT Corporation announced today that it will host a key opinion leader conference......
    Read more ...

     

  • Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12

    10 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 6, 2019 /PRNewswire/ - Tocagen Inc. , a clinical-stage, cancer-selective gene therapy company, today announced it will report its third quarter 2019 financial results and business progress on Tuesday, November 12, 2019......
    Read more ...

     

  • Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update

    10 days ago - By San Diego Biotechnology

    Company on Track for Amphora NDA Resubmission to the U.S. FDAPhase 2b AMPREVENCE Trial Results Anticipated in Q4 2019Management to Host Conference Call Thursday, November 7, 2019 at 11:00 a.m. EST
    SAN DIEGO, Nov. 6, 2019 /PRNewswire/ - Evofem Biosci......
    Read more ...